| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Greenwich LifeSciences Inc (NASDAQ: GLSI)
GLSI Technical Analysis
5
| As on 9th Jun 2023 GLSI SHARE Price closed @ 10.90 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 13.61 & Strong Sell for SHORT-TERM with Stoploss of 21.09 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GLSISHARE Price
| Open | 11.55 | Change | Price | % |
| High | 11.63 | 1 Day | -0.64 | -5.55 |
| Low | 10.90 | 1 Week | 0.07 | 0.65 |
| Close | 10.90 | 1 Month | 0.04 | 0.37 |
| Volume | 12674 | 1 Year | -19.59 | -64.25 |
| 52 Week High 30.49 | 52 Week Low 7.14 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| GLSI Daily Charts |
GLSI Intraday Charts |
Whats New @ Bazaartrend |
GLSI Free Analysis |
|
|
GLSI Important Levels Intraday
| RESISTANCE | 12.31 |
| RESISTANCE | 11.86 |
| RESISTANCE | 11.58 |
| RESISTANCE | 11.30 |
| SUPPORT | 10.50 |
| SUPPORT | 10.22 |
| SUPPORT | 9.94 |
| SUPPORT | 9.49 |
GLSI Forecast April 2024
| 4th UP Forecast | 31.62 |
| 3rd UP Forecast | 24.97 |
| 2nd UP Forecast | 20.87 |
| 1st UP Forecast | 16.76 |
| 1st DOWN Forecast | 5.04 |
| 2nd DOWN Forecast | 0.93 |
| 3rd DOWN Forecast | -3.17 |
| 4th DOWN Forecast | -9.82 |
GLSI Weekly Forecast
| 4th UP Forecast | 26.22 |
| 3rd UP Forecast | 21.31 |
| 2nd UP Forecast | 18.27 |
| 1st UP Forecast | 15.23 |
| 1st DOWN Forecast | 6.57 |
| 2nd DOWN Forecast | 3.53 |
| 3rd DOWN Forecast | 0.49 |
| 4th DOWN Forecast | -4.42 |
GLSI Forecast2024
| 4th UP Forecast | 56.26 |
| 3rd UP Forecast | 41.71 |
| 2nd UP Forecast | 32.72 |
| 1st UP Forecast | 23.73 |
| 1st DOWN Forecast | -1.93 |
| 2nd DOWN Forecast | -10.92 |
| 3rd DOWN Forecast | -19.91 |
| 4th DOWN Forecast | -34.46 |
Greenwich LifeSciences Inc ( NASDAQ USA Symbol : GLSI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GLSI Business Profile
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent recurrence of breast cancer following surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas. Address: Building 14, Stafford, TX, United States, 77477
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service